12:00 AM
Nov 22, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Oleptro trazodone regulatory update

Labopharm said it received notice from Actavis South Atlantic LLC, a subsidiary of Actavis Group (Hafnarfjordur, Iceland), that the subsidiary submitted a Paragraph IV certification to FDA as...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >